Literature DB >> 15017654

Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia.

Wendy Hall1, Martin Buckley, Paul Crotty, Colm A O'Morain.   

Abstract

BACKGROUND & AIMS: Mast cells might be involved in pathogenesis of functional dyspepsia because they can release a wide range of potent mediators, capable of altering gastric nerve and muscle function. This study aimed to determine whether mast cell numbers were increased in the gastric mucosa of patients with functional dyspepsia compared to control subjects.
METHODS: Biopsy samples were taken from the antrum and corpus of 111 patients: 20 asymptomatic control subjects, 62 patients with Rome criteria functional dyspepsia (33 Helicobacter pylori positive, 29 H. pylori negative), and 29 inflammatory control subjects (H. pylori positive). Mast cells were detected immunohistochemically by using a mouse monoclonal antibody specific for tryptase. Quantification was performed with light microscopy, and results were expressed as mast cells/mm(2) +/- standard error of mean.
RESULTS: Mast cells were significantly increased in H. pylori negative functional dyspepsia samples compared to normal control samples in the antrum (230.1 +/- 11.3 vs. 94.8 +/- 8.4, P < 0.001) and corpus (264.1 +/- 27.1 vs. 123.9 +/- 11.5, P = 0.001). Mast cells were also significantly increased in the antrum of patients with H. pylori positive functional dyspepsia compared to asymptomatic control subjects (166.5 +/- 17.0 vs. 94.8 +/- 8.4, P < 0.03). However, there was no significant difference between mast cell numbers in patients with H. pylori positive functional dyspepsia compared to inflammatory control subjects.
CONCLUSIONS: Mast cells are increased in functional dyspepsia, independently of inflammation. This might contribute to the pathogenesis of functional dyspepsia by altering signaling in the brain-gut axis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15017654     DOI: 10.1053/s1542-3565(03)00184-8

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  20 in total

Review 1.  Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 2.  The role of eosinophils and mast cells in intestinal functional disease.

Authors:  Marjorie M Walker; Alasdair Warwick; Chuin Ung; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2011-08

Review 3.  Role of Helicobacter pylori in functional dyspepsia.

Authors:  Colm O'Morain
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

4.  Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

Authors:  Mar Guilarte; Javier Santos; Inés de Torres; Carmen Alonso; María Vicario; Laura Ramos; Cristina Martínez; Francesc Casellas; Esteban Saperas; Juan Ramón Malagelada
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

Review 5.  Pathogenesis and therapy for idiopathic dyspepsia.

Authors:  Jan Tack; Sébastien Kindt
Journal:  Curr Gastroenterol Rep       Date:  2005-12

Review 6.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

7.  Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia.

Authors:  Hai-Peng Yuan; Zhen Li; Youcan Zhang; Xiao-Pei Li; Fu-Kang Li; Yan-Qing Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia.

Authors:  Craig A Friesen; Zhiyue Lin; Meenal Singh; Vivekanand Singh; Jennifer V Schurman; Nanci Burchell; Jose T Cocjin; Richard W McCallum
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

Review 9.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

10.  Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.

Authors:  Craig A Friesen; Nancy A Neilan; Jennifer V Schurman; Debra L Taylor; Gregory L Kearns; Susan M Abdel-Rahman
Journal:  BMC Gastroenterol       Date:  2009-05-11       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.